MMPROFILER

WIPO WIPO 2015

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MMPROFILER was filed as Figurative mark on 10/22/2015 at the World Intellectual Property Organization.

Trademark Details Last update: July 29, 2022

Trademark form Figurative mark
File reference 1293798
Register number 0979457
Countries European Community United States of America (USA) Switzerland
Base trademark BX No. 0979457, October 8, 2015
Application date October 22, 2015
Expiration date October 22, 2025

Trademark owner

Lichtenauerlaan 40
3062 ME Rotterdam
NL

Trademark representatives

Carnegieplein 5 2517 KJ Den Haag NL

goods and services

05 Molecular diagnostic test reagents; molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer; molecular diagnostic test reagents, inter alia on the basis of microarray technology (next generation) sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile, reagents for use in medical genetic testing for the measurement of gene aberrations and mutations, clinical multiplex (research) testing, inter alia, for the determination of the genetic sub-type of a patient; prognostic test reagents; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; reagents and other supplies for diagnostic testing; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells
09 Software; software and algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the (complex) genetic properties of the patient sample; software for interpreting the obtained raw genetic information for inter alia laboratory users, molecular biologists, pathologists, physicians and patients, comprehensive and relevant information (such as the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of the disease or clinical consequence thereof as well as poor or good prognosis, whether or not in combination with a specific treatment); validated software for secure IT infrastructures for clinical purposes; databases containing anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples
35 Compilation of medical and veterinary information
42 Scientific research for the benefit of the development of molecular diagnostic tests; developing software for performing diagnostic tests for medical purposes, as well as developing software and algorithms and / or databases for translation (reading), analyzing and interpreting test results; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers, testing, and (corresponding) methods of treatment; leasing of computer software for reading test results; development and testing services for the certification of quality or standards of (molecular) diagnostic tests
44 Medical analysis services; analysis of medical and veterinary test scores and data for others; medical and veterinary information services provided via the internet

Trademark history

Date Document number Area Entry
November 9, 2017 2017/45 Gaz US Rejection
March 13, 2017 2017/11 Gaz CH Rejection
September 1, 2016 2016/36 Gaz EM Rejection
March 31, 2016 2016/18 Gaz US Rejection
October 22, 2015 2016/11 Gaz BX Registration

ID: 141293798